Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
2.160
-0.050 (-2.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Generation Bio Co. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 13.17 | 5.9 | - | - | - | - | |
Cost of Revenue | 66.59 | 79.82 | 74.2 | 74.72 | 49.14 | - | |
Gross Profit | -53.41 | -73.91 | -74.2 | -74.72 | -49.14 | - | |
Selling, General & Admin | 58.48 | 64.65 | 66.98 | 44.38 | 31.98 | 21.72 | |
Research & Development | - | - | - | - | - | 40.58 | |
Operating Expenses | 58.48 | 64.65 | 66.98 | 44.38 | 31.98 | 62.3 | |
Operating Income | -111.89 | -138.56 | -141.18 | -119.1 | -81.11 | -62.3 | |
Interest & Investment Income | 6 | - | - | - | - | 0.98 | |
Other Non Operating Income (Expenses) | 6.3 | 11.95 | 4.54 | -0.05 | 0.59 | - | |
EBT Excluding Unusual Items | -99.6 | -126.61 | -136.64 | -119.15 | -80.52 | -61.33 | |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.01 | |
Pretax Income | -158.43 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
Net Income | -158.43 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
Net Income to Common | -158.43 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
Shares Outstanding (Basic) | 66 | 64 | 58 | 56 | 27 | 5 | |
Shares Outstanding (Diluted) | 66 | 64 | 58 | 56 | 27 | 5 | |
Shares Change (YoY) | 8.53% | 10.96% | 3.23% | 106.54% | 476.06% | 41.22% | |
EPS (Basic) | -2.39 | -1.96 | -2.35 | -2.12 | -2.95 | -12.96 | |
EPS (Diluted) | -2.39 | -1.96 | -2.35 | -2.12 | -2.95 | -12.96 | |
Free Cash Flow | -110.23 | -60.14 | -111.25 | -97.78 | -75.66 | -60.33 | |
Free Cash Flow Per Share | -1.66 | -0.93 | -1.91 | -1.74 | -2.78 | -12.75 | |
Operating Margin | -849.35% | -2346.93% | - | - | - | - | |
Profit Margin | -1202.56% | -2144.51% | - | - | - | - | |
Free Cash Flow Margin | -836.71% | -1018.67% | - | - | - | - | |
EBITDA | -106.7 | -133.3 | -136.05 | -114.57 | -77.68 | -60.44 | |
D&A For EBITDA | 5.19 | 5.26 | 5.13 | 4.53 | 3.43 | 1.86 | |
EBIT | -111.89 | -138.56 | -141.18 | -119.1 | -81.11 | -62.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.